Skip to main content

PROTHENA CORP PUBLIC LTD CO

For the period ended Jun 30, 2024. Filed Aug 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 8, 2024

PRTA$8.78+10.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 5. OTHER INFORMATION

On May 7, 2024, Tran B. Nguyen, Chief Strategy Officer and Chief Financial Officer, terminated a Rule 10b5-1 trading arrangement that had been adopted on February 26, 2024, and intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 510,150 shares of the Company’s ordinary shares until May 15, 2025. On May 10, 2024, Mr. Nguyen adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 39,844 shares of the Company’s ordinary shares until December 31, 2024.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.